• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Thera (NQ: VKTX )

    63.83 -2.15 (-3.26%)
    Streaming Delayed Price Updated: 10:29 AM EDT, Jul 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,389,603
    Open 66.01
    Bid (Size) 63.70 (1)
    Ask (Size) 63.96 (4)
    Prev. Close 65.98
    Today's Range 63.40 - 68.47
    52wk Range 8.280 - 99.41
    Shares Outstanding 99,581,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
    The Federal Reserve's fight against inflation may soon yield financial benefits. 
    Via The Motley Fool
    Topics Economy
    Exposures Interest Rates
    The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.
    One preliminary piece of evidence is sending its shares higher. 
    Via The Motley Fool

    Performance

    YTD
    +249.18%
    +249.18%
    1 Month
    +20.41%
    +20.41%
    3 Month
    -15.37%
    -15.37%
    6 Month
    +166.96%
    +166.96%
    1 Year
    +340.21%
    +340.21%

    More News

    Read More
    Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
    Via The Motley Fool
    ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
    Via Benzinga
    Is Viking Therapeutics a Millionaire-Maker Stock?
    Via The Motley Fool
    Viking Therapeutics's Options: A Look at What the Big Money is Thinking
    Via Benzinga
    Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
    Via Investor's Business Daily
    Why Weight Loss Drug Developer Stocks Tumbled on Thursday
    Via The Motley Fool
    Novo Nordisk Shares Decline Amid Competitive Pressure
    Via Benzinga
    Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings
    Via Benzinga
    Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
    Via Benzinga
    Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
    Via Benzinga
    IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Why Eli Lilly and Company Shares Are Moving Lower On Thursday
    Via Benzinga
    Viking Therapeutics: Pharma Stock Soars on Positive Earnings
    Via MarketBeat
    Topics Earnings
    Exposures Financial
    Why Viking Therapeutics Stock Is Skyrocketing Today
    Via The Motley Fool
    CON Stock: 7 Things to Know as Concentra Group Starts Trading Today
    Via InvestorPlace
    Topics Initial Public Offering
    Exposures Securities Market
    Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo Nordisk
    Via Investor's Business Daily
    Goodbye Open Seating! Southwest Airlines Announces Major Policy Shift.
    Via InvestorPlace
    Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Morgan Stanley Predicts Triple-Digit Rally for These 3 Stocks
    Via InvestorPlace
    Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.